Status:
NOT_YET_RECRUITING
129Xe MRI in Pediatric Population With BPD
Lead Sponsor:
Xemed LLC
Collaborating Sponsors:
Children's Hospital of Philadelphia
Conditions:
Bronchopulmonary Dysplasia
Eligibility:
All Genders
Up to 1 years
Phase:
PHASE1
Brief Summary
Hyperpolarized (HP) gas magnetic resonance imaging (MRI) of the lungs offers additional information that cannot be obtained with CT scan, the current gold standard for imaging this disorder. As a noni...
Detailed Description
The most common respiratory complication of preterm birth, bronchopulmonary dysplasia (BPD), defined by a clinically assessed need for supplemental oxygen support at 36 weeks post-menstrual age, has a...
Eligibility Criteria
Inclusion
- Infants admitted to the NICU at the Children's Hospital of Philadelphia with bronchopulmonary dysplasia who are followed by the Chronic Lung Disease Program.
- Subjects mechanically ventilated either via and endotracheal tube or via a tracheostomy.
- Subjects already receiving sedation as part of clinical care.
Exclusion
- \- Infants whom the primary care team deems to be unstable for transport to MRI
Key Trial Info
Start Date :
August 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2031
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04035629
Start Date
August 1 2026
End Date
December 31 2031
Last Update
April 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104